Regeneron files Form 13F reporting $33.8M holdings
Regeneron Pharmaceuticals, Inc. filed a Form 13F holdings report disclosing 2 holdings with an aggregate reported market value of $33,799,428.
Rhea-AI Filing Summary
Regeneron Pharmaceuticals, Inc. filed a Form 13F holdings report disclosing 2 holdings with an aggregate reported market value of $33,799,428. The report is signed by Leonard Brooks, Senior Vice President, Treasurer, and dated 02-06-2026. The filing lists the manager's address as 777 Old Saw Mill River Road, Tarrytown, NY.
Positive
- None.
Negative
- None.
Insights
Routine Form 13F filing listing two reported positions totaling $33.8M.
This is a standard quarterly disclosure by an institutional manager showing holdings as required under Section 13(f). The report summary lists 2 information-table entries and a total reported market value of $33,799,428.
Timing and valuation are snapshot-based; subsequent filings may show changes. The filing was signed by Leonard Brooks on 02-06-2026, indicating the reporting manager attested to completeness.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did REGN report on this Form 13F?
Does this Form 13F show trades or transactions for REGN?
Who signed the Form 13F for Regeneron Pharmaceuticals?
How many holdings and what total value did the filing report?
Where is the reporting manager located for this Form 13F?
AI-generated analysis. How Rhea-AI works. Not financial advice.